Towards translation of 212Pb as a clinical therapeutic; getting the lead in! (Q35028126)

5 August 2017

title

Towards translation of 212Pb as a clinical therapeutic; getting the lead in! (English)

1 reference

5 August 2017

Kwon Yong

1

1 reference

5 August 2017

Martin W Brechbiel

series ordinal

2

1 reference

5 August 2017

language of work or name

English

0 references

publication date

4 March 2011

1 reference

5 August 2017

1 reference

5 August 2017

volume

40

1 reference

5 August 2017

issue

23

1 reference

5 August 2017

page(s)

6068-6076

1 reference

Radioimmunotherapy of non-Hodgkin's lymphoma: a critical appraisal

5 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109156

Multimodality therapy: potentiation of high linear energy transfer radiation with paclitaxel for the treatment of disseminated peritoneal disease

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109156

Targeted radiotherapy: microgray doses and the bystander effect

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109156

203Pb-labeled alpha-melanocyte-stimulating hormone peptide as an imaging probe for melanoma detection

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109156

Targeted alpha-particle radiotherapy with 211At-labeled monoclonal antibodies

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109156

Alpha-particle radioimmunotherapy of disseminated peritoneal disease using a (212)Pb-labeled radioimmunoconjugate targeting HER2.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109156

Pretargeted radioimmunotherapy in tumored mice using an in vivo 212Pb/212Bi generator.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109156

Synthesis, characterization, and x-ray crystal structures of cyclam derivatives. 8. Thermodynamic and kinetic appraisal of lead(II) chelation by octadentate carbamoyl-armed macrocycles.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109156

Purification of cyclotron-produced 203Pb for labeling Herceptin

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109156

Targeted alpha therapy for cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109156

Antibody-targeted radiation cancer therapy

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109156

The development of the alpha-particle emitting radionuclides 212Bi and 213Bi, and their decay chain related radionuclides, for therapeutic applications

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109156

The HER-2/neu oncogene in tumors of the gastrointestinal tract

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109156

HER-2/neu as a therapeutic target in non-small cell lung cancer, prostate cancer, and ovarian cancer.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109156

Internal radionuclide radiation dosimetry: a review of basic concepts and recent developments

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109156

Generating improved single-chain Fv molecules for tumor targeting

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109156

Delayed lethality, apoptosis and micronucleus formation in human fibroblasts irradiated with X-rays or alpha-particles.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109156

Studies of bystander effects in human fibroblasts using a charged particle microbeam

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109156

Heavy-ion radiobiology: new approaches to delineate mechanisms underlying enhanced biological effectiveness

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109156

Radioimmunotherapy targeting of HER2/neu oncoprotein on ovarian tumor using lead-212-DOTA-AE1.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109156

Inactivation of individual mammalian cells by single alpha-particles

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109156

Medium from irradiated human epithelial cells but not human fibroblasts reduces the clonogenic survival of unirradiated cells

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109156

Synergy of Taxol and radioimmunotherapy with yttrium-90-labeled chimeric L6 antibody: efficacy and toxicity in breast cancer xenografts

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109156

Mutagenic effects of a single and an exact number of alpha particles in mammalian cells

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109156

Radiotoxicity of gadolinium-148 and radium-223 in mouse testes: relative biological effectiveness of alpha-particle emitters in vivo

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109156

Microdosimetry and radiocurability: modelling targeted therapy with beta-emitters

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109156

Biological effect of lead-212 localized in the nucleus of mammalian cells: role of recoil energy in the radiotoxicity of internal alpha-particle emitters

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109156

Initial events in the cellular effects of ionizing radiations: clustered damage in DNA.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109156

The development of alpha-emitting radionuclide lead 212 for the potential treatment of ovarian carcinoma.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109156

In vivo comparison of macrocyclic and acyclic ligands for radiolabeling of monoclonal antibodies with 177Lu for radioimmunotherapeutic applications

8 July 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0DT01387K

Synthesis and evaluation of novel bifunctional chelating agents based on 1,4,7,10-tetraazacyclododecane-N,N',N",N"'-tetraacetic acid for radiolabeling proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0DT01387K

Structural effects of the lone pair on lead(II), and parallels with the coordination geometry of mercury(II). Does the lone pair on lead(II) form H-bonds? Structures of the lead(II) and mercury(II) complexes of the pendant-donor macrocycle DOTAM (1,

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0DT01387K

Combined 90Yttrium-DOTA-labeled PAM4 antibody radioimmunotherapy and gemcitabine radiosensitization for the treatment of a human pancreatic cancer xenograft

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0DT01387K

Combined modality radioimmunotherapy. Promise and peril

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0DT01387K

Melanoma therapy via peptide-targeted {alpha}-radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0DT01387K

The MIRD perspective 1999. Medical Internal Radiation Dose Committee.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109156

High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model

25 October 2018

1 reference

12 December 2020

Values of "S," <z1>, and <(z1)2> for dosimetry using alpha-particle emitters

1 reference

12 December 2020

Studies on the red marrow dosimetry in radioimmunotherapy: an experimental investigation of factors influencing the radiation-induced myelotoxicity in therapy with beta-, Auger/conversion electron-, or alpha-emitters

1 reference

12 December 2020

Tumor control probability model for alpha-particle-emitting radionuclides

1 reference

12 December 2020

Improved synthesis of the bifunctional chelating agent 1,4,7,10-tetraaza-N-(1-carboxy-3-(4-nitrophenyl)propyl)-N',N'',N'''-tri s(acetic acid)cyclododecane (PA-DOTA)

1 reference

12 December 2020

Synthesis, characterization, and evaluation of a novel bifunctional chelating agent for the lead isotopes 203Pb and 212Pb

1 reference

12 December 2020

Survival of human lung epithelial cells following in vitro alpha-particle irradiation with absolute determination of the number of alpha-particle traversals of individual cells

1 reference

12 December 2020

A 212Pb generator based on a 228Th source

1 reference

12 December 2020

Theoretical estimation of absorbed dose to organs in radioimmunotherapy using radionuclides with multiple unstable daughters

1 reference

12 December 2020

Convenient synthesis of bifunctional tetraaza macrocycles

1 reference

12 December 2020

Potentiation of high-LET radiation by gemcitabine: targeting HER2 with trastuzumab to treat disseminated peritoneal disease

1 reference

12 December 2020

(212)Pb@C(60) and its water-soluble derivatives: synthesis, stability, and suitability for radioimmunotherapy

1 reference

12 December 2020

Metal complexes of cyclic tetra-azatetra-acetic acids

1 reference

12 December 2020

Coordination of bismuth and lead in porphyrins: towards an in-situ generator for alpha-radiotherapy?

1 reference

12 December 2020

Backbone-substituted DTPA ligands for 90Y radioimmunotherapy.

1 reference

12 December 2020

Nonuniformity of tumor dose in radioimmunotherapy

1 reference

12 December 2020

Improved in vivo stability and tumor targeting of bismuth-labeled antibody

1 reference

12 December 2020

An improved generator for the production of 212Pb and 212Bi from 224Ra

1 reference

12 December 2020

Radioimmunotherapy with alpha-particle-emitting immunoconjugates

1 reference

12 December 2020

The effect of the alpha-emitting radionuclide lead-212 on human ovarian carcinoma: a potential new form of therapy

1 reference

12 December 2020

Properties of liposomes containing 212Pb

1 reference

12 December 2020

Isotopic generator for 212Pb and 212Bi

1 reference

12 December 2020

Experimental radioimmunotherapy

1 reference

12 December 2020

The use of 212Pb-labeled monoclonal antibody in the treatment of murine erythroleukemia

1 reference

12 December 2020

Evaluation of dithiol chelating agents as potential adjuvants for anti-IL-2 receptor lead or bismuth alpha radioimmunotherapy

1 reference

12 December 2020

212Bi-DOTMP: an alpha particle emitting bone-seeking agent for targeted radiotherapy

1 reference

12 December 2020

Stereochemical influence on the stability of radio-metal complexes in vivo. Synthesis and evaluation of the four stereoisomers of 2-(p-nitrobenzyl)-trans-CyDTPA

1 reference

12 December 2020

In vivo evaluation of a lead-labeled monoclonal antibody using the DOTA ligand

1 reference

12 December 2020

Identifiers

DOI

10.1039/C0DT01387K

1 reference

5 August 2017

1 reference

5 August 2017

1 reference